Skip to main content

ORIGINAL RESEARCH article

Front. Surg., 11 May 2022
Sec. Surgical Oncology

RETRACTED: Longitude Variation of the microRNA-497/FGF-23 Axis during Treatment and Its Linkage with Neoadjuvant/Adjuvant Trastuzumab-Induced Cardiotoxicity in HER2-Positive Breast Cancer Patients

Retracted
\r\nHui LiuHui LiuXiaoyan HuXiaoyan HuLingyun WangLingyun WangTao DuTao DuJing FengJing FengMing LiMing LiLei LiuLei LiuXiaofang Liu
\r\nXiaofang Liu*
  • Hematology and Oncology Department, The First People’s Hospital of Guiyang, Guiyang, China

This article has been retracted. Please follow the link to the full retraction notice for details.

Citation: Liu H, Hu X, Wang L, Du T, Feng J, Li M, Liu L and Liu X (2022) Longitude Variation of the microRNA-497/FGF-23 Axis during Treatment and Its Linkage with Neoadjuvant/Adjuvant Trastuzumab-Induced Cardiotoxicity in HER2-Positive Breast Cancer Patients. Front. Surg. 9:862617. doi: 10.3389/fsurg.2022.862617

Received: 26 January 2022; Accepted: 11 April 2022;
Published: 11 May 2022;
Retracted: 11 October 2023.

Edited by:

Einar Kristiansen, Norwegian Radium Hospital, Oslo University Hospital, Norway

Reviewed by:

Ruoyu Deng, Fudan University, China
Xiaoyi Zhang, Central Hospital of Wuhan, Huazhong University of Science and Technology, China
Yanbin Ren, HanDan Central Hospital, China
Yanan Liu, Zhuhai Golden Bay Center Hospital, China

Specialty section: This article was submitted to Surgical Oncology, a section of the journal Frontiers in Surgery

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.